Pluvicto (lutetium Lu 177 vipivotide tetraxetan) - Novartis
Lutathera (lutetium Lu 177 dotatate) - Novartis
Open-Source and Spreadsheet-Based Dosimetry as Alternatives to Commercial Software in Lutetium177 Radioligand Therapy (EANM 2026) - Sep 29, 2026 - Abstract #EP-1025; "Aim/Introduction: To compare different methodologies for performing patient dosimetry in treatments with Lutetium-177 dotatate (Lu-177-DOTATATE) and Lutetium-177 vipivotide tetraxetan (Lu-177-PSMA). Dosimetric values obtained with 3DSlicer and spreadsheet-based calculations were generally comparable to those derived from MIM software. Observed differences in MTP analyses are mainly attributable to variations in curve-fitting methods used for time-activity modeling. For single-time-point dosimetry in the first cycle, the Madsen approach provided better agreement with MTP-based reference values compared with the Hänscheid method." 
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
L. Lampertico 1, 2; G. Muti 2; C. Carbonini 2; C. RomanĂ² 2; A. Scarale 3; P. Colombo 2; C. Rossetti 3
 
Sep 29, 2026
 
Prev Next